EP 2035005 A2 20090318 - THERAPY USING CYTOKINE INHIBITORS
Title (en)
THERAPY USING CYTOKINE INHIBITORS
Title (de)
THERAPIE MIT ZYTOKINHEMMERN
Title (fr)
THÉRAPIE À BASE D'INHIBITEURS DE CYTOKINE
Publication
Application
Priority
- US 2007070547 W 20070606
- US 81226806 P 20060609
- US 83307806 P 20060724
- US 83527006 P 20060803
Abstract (en)
[origin: WO2007146712A2] The present invention relates to methods of treating, preventing, modifying and managing cytokine-mediated disorders or related disorders, which comprise the administration of a compound, such as a cytokine inhibitor, alone or in combination with known therapeutics. The invention also relates to pharmaceutical compositions and dosing regimens using the disclosed compounds. In particular, the invention relates to the use of compounds as disclosed herein, optionally in conjunction with other therapies, for the treatment of autoimmune diseases, inflammatory diseases, cardiovascular diseases, and cancer.
IPC 8 full level
A61K 31/4965 (2006.01)
CPC (source: EP)
A61K 31/501 (2013.01); A61P 1/00 (2017.12); A61P 3/00 (2017.12); A61P 9/00 (2017.12); A61P 11/00 (2017.12); A61P 17/00 (2017.12); A61P 19/00 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); Y02A 50/30 (2017.12)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007146712 A2 20071221; WO 2007146712 A3 20081127; AR 061273 A1 20080813; AU 2007257959 A1 20071221; CA 2691214 A1 20071221; CL 2007001670 A1 20080118; EP 2035005 A2 20090318; EP 2035005 A4 20110706; PE 20080935 A1 20080802; TW 200814998 A 20080401
DOCDB simple family (application)
US 2007070547 W 20070606; AR P070102483 A 20070608; AU 2007257959 A 20070606; CA 2691214 A 20070606; CL 2007001670 A 20070608; EP 07798190 A 20070606; PE 2007000714 A 20070608; TW 96120764 A 20070608